Binkley SN[au] - Search Results

Year	Number of Results
1995	2
1996	2
1998	2
1999	1
2001	1
2002	1
2022	0

1

Autoactivation and activation of the cytochrome P450s.

Ekins S, Ring BJ, Binkley SN, Hall SD, Wrighton SA. Ekins S, et al. Among authors: binkley sn. Int J Clin Pharmacol Ther. 1998 Dec;36(12):642-51. Int J Clin Pharmacol Ther. 1998. PMID: 9877001

2

Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.

Ring BJ, Eckstein JA, Gillespie JS, Binkley SN, VandenBranden M, Wrighton SA. Ring BJ, et al. Among authors: binkley sn. J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50. J Pharmacol Exp Ther. 2001. PMID: 11356927

3

Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices.

VandenBranden M, Wrighton SA, Ekins S, Gillespie JS, Binkley SN, Ring BJ, Gadberry MG, Mullins DC, Strom SC, Jensen CB. VandenBranden M, et al. Among authors: binkley sn. Drug Metab Dispos. 1998 Nov;26(11):1063-8. Drug Metab Dispos. 1998. PMID: 9806947

4

The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.

Ring BJ, Gillespie JS, Binkley SN, Campanale KM, Wrighton SA. Ring BJ, et al. Among authors: binkley sn. Drug Metab Dispos. 2002 Sep;30(9):957-61. doi: 10.1124/dmd.30.9.957. Drug Metab Dispos. 2002. PMID: 12167559

5

Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.

Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ, Wrighton SA. Dantzig AH, et al. Among authors: binkley sn. J Pharmacol Exp Ther. 1999 Aug;290(2):854-62. J Pharmacol Exp Ther. 1999. PMID: 10411602

6

Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.

VandenBranden M, Ring BJ, Binkley SN, Wrighton SA. VandenBranden M, et al. Among authors: binkley sn. Pharmacogenetics. 1996 Feb;6(1):81-91. doi: 10.1097/00008571-199602000-00007. Pharmacogenetics. 1996. PMID: 8845864

7

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.

Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA. Ring BJ, et al. Among authors: binkley sn. Br J Clin Pharmacol. 1996 Mar;41(3):181-6. doi: 10.1111/j.1365-2125.1996.tb00180.x. Br J Clin Pharmacol. 1996. PMID: 8866916 Free article.

8

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

Ring BJ, Binkley SN, Roskos L, Wrighton SA. Ring BJ, et al. Among authors: binkley sn. J Pharmacol Exp Ther. 1995 Dec;275(3):1131-5. J Pharmacol Exp Ther. 1995. PMID: 8531073

9

Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.

Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighton SA. Sharer JE, et al. Among authors: binkley sn. Drug Metab Dispos. 1995 Nov;23(11):1231-41. Drug Metab Dispos. 1995. PMID: 8591724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results